Bin Li
Associate Director
Takeda Pharmaceuticals
USA
Biography
Dr. Bin Li leads a computational biology team at translational medicine department, Takeda Pharmaceuticals International Co. His team provides computational supports on translational medicine research for various Takeda compounds. They develop computational methods for clinical biomarker research, build predictive models for biomarker and patient stratification, and design/implement translational data repositories. His team is also responsible for method evaluation and pipeline building for various NGS platforms, including WES, RNA-seq, and targeted NGS panels.
Research Interest
Computational biology, predictive modeling, biomarker, network analysis, precision medicine